| EIMGX | WCMLX | EIMGX / WCMLX | |
| Total Expense Ratio | 0.88 | 0.99 | 89% |
| Annual Report Gross Expense Ratio | 0.88 | 1.79 | 49% |
| Fund Existence | 16 years | 6 years | - |
| Gain YTD | -6.433 | 6.454 | -100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 100000 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 117M | 43.1M | 271% |
| Annual Yield % from dividends | 0.40 | 0.00 | - |
| Returns for 1 year | -13.83 | -2.98 | 465% |
| Returns for 3 years | 5.96 | 22.89 | 26% |
| Returns for 5 years | 11.58 | 4.74 | 244% |
| Returns for 10 years | 29.93 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNIX | 81.53 | 0.73 | +0.90% |
| Janus Henderson Global Life Sciences I | |||
| IINCX | 25.73 | 0.16 | +0.63% |
| Macquarie International Core Eq R6 | |||
| PCSVX | 17.44 | 0.05 | +0.29% |
| PACE Small/Medium Co Value Equity P | |||
| SAGAX | 60.41 | -0.18 | -0.30% |
| Virtus Zevenbergen Innovative Gr Stk A | |||
| ICPAX | 7.12 | -0.06 | -0.84% |
| Integrity Mid-North American Resources A | |||